跳至主要内容
临床试验/NCT02023554
NCT02023554已完成不适用

A Pharmacokinetic Drug Interaction Study to Evaluate the Effect of Azithromycin on the Steady-State Plasma Levels of Theophylline in a Chinese Population

Zhujiang Hospital1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2013年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
steady-state plasma concentration of theophylline

研究概览

简要总结

Macrolides are potent inhibitors of cytochrome P450 isoenzyme 3A4(CYP3A4)and thus interfere with the pharmacokinetics of many other drugs that are metabolised by this enzyme like theophylline.The aim of this study is to determine whether azithromycin can effect theophylline metabolism in patients.

详细描述

In this non-blinded,auto-control study,patients with Chronic Obstructive Pulmonary Disease(COPD)or asthma will serve as their own controls during the 2-week treatment phase.The subjects will be co-administered oral doses of sustained release theophylline (100mg tablets,twice daily) and azithromycin (2x250mg capsules,once daily )in the first week.Then patients will received theophylline therapy alone with the same dose in the second week.Blood samples for the measurement of theophylline plasma concentrations will be collected on Days 8 and 15 prior to dosing.All adverse events whether elicited by query, spontaneously reported or observed by clinic staff will be evaluated by the investigator and reported in the subject's case report form.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with COPD or asthma,aged 18-75 years;
  • regularly visiting our hospital;
  • meeting the indications for azithromycin and theophylline simultaneously;

排除标准

  • patients with renal or hepatic dysfunction;
  • patients with congestive heart failure;
  • patients with hypothyroidism or hyperthyroidism;
  • patients taking drugs likely to affect the theophylline metabolism in the preceding week;
  • patients with severe chronic obstructive pulmonary disease,asthma or respiratory infection;

研究组 & 干预措施

Theophylline with azithromycin

Experimental

steady-state plasma concentration of theophylline in the presence of azithromycin

干预措施: Theophylline with azithromycin (Drug)

Theophylline alone

Active Comparator

steady-state plasma concentration of theophylline alone

干预措施: Theophylline alone (Drug)

结局指标

主要结局

steady-state plasma concentration of theophylline

时间窗: blood samples for theophylline will be collected on Days 8 and 15 before dosing

Theophylline and it's metabolite(1,3-dimethyluric) blood concentration

次要结局

未报告次要终点

研究者

发起方
Zhujiang Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验